Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cancer Pain × fulranumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Cancer Pain 1

Interventions

Morphine 2 resiniferatoxin 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 alvimopan 1 Surveys and Questionnaires 1 Standard of Care 1 Pain Management 1 Oxycodone 1 Massage 1 Lidocaine 1 Lenalidomide 1 Ketamine 1 Gels 1 Fentanyl 1 Dronabinol 1 Cannabidiol 1 Animal Assisted Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00929188 2016-01-22

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

Janssen Research & Development, LLC

Phase 2 Completed

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡